Shares of AstraZeneca Plc were losing around 4 percent in the morning trade in London as well as in pre-market activity on Nasdaq after the British drug maker reported Friday a loss in its third quarter, despite strong growth in revenues. Looking ahead, the covid vaccine maker said its earnings guidance for the full year 2021 remains unchanged.
from RTT - Earnings https://ift.tt/3CaXkG3
via IFTTT
No comments:
Post a Comment